Lv5
1110 积分 2024-09-22 加入
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
1个月前
已完结
Mapping the effectiveness and risks of GLP-1 receptor agonists
3个月前
已完结
Definition and diagnostic criteria of clinical obesity
3个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
7个月前
已完结
皖公网安备34019202002308
